Table 3. Age- and Race/Ethnicity-Adjusted Trends in the Prevalence of Ideal Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016.
| Proportion With Ideal Levels of HDL, Non-HDL, and Total Cholesterol, % (95% CI)a | β (95% CI), %/y | Proportion With Ideal Levels of All Lipids and Apolipoprotein B, % (95% CI)a,b | β (95% CI), %/y | |||
|---|---|---|---|---|---|---|
| 2007-2008 | 2015-2016 | 2007-2008 | 2013-2014 | |||
| All youths | 42.1 (39.6 to 44.7) | 51.4 (48.5 to 54.2) | 1.1 (0.6 to 1.5) | |||
| Age group, y | ||||||
| 6-11 | 41.0 (37.0 to 45.0) | 53.9 (49.7 to 58.0) | 1.4 (0.8 to 2.1) | |||
| 12-19 | 42.3 (38.8 to 45.8) | 49.0 (45.2 to 52.9) | 0.8 (0.2 to 1.3) | 39.6 (33.7 to 45.4) | 46.8 (40.9 to 52.6) | 1.0 (−0.2 to 2.3) |
The following ideal levels were defined by the 2011 National Heart, Lung, and Blood Institute Expert Panel Guidelines: total cholesterol, less than 170 mg/dL; high-density lipoprotein (HDL) cholesterol, greater than 45 mg/dL; non-HDL cholesterol, less than 120 mg/dL; triglycerides, less than 90 mg/dL; low-density lipoprotein cholesterol (LDL), less than 110 mg/dL; and apolipoprotein B, less than 90 mg/dL.20 All estimates are based on population-weighted data from the National Health and Nutrition Examination Survey. The unweighted sample size ranges for each lipid and survey cycle are as follows: HDL, non-HDL, and total cholesterol in 2007-2008, the minimum was 987 (youths aged 6-11 years) and the maximum was 2055 (all youths) and in 2015-2016, minimum of 992 (youths aged 6-11 years) and maximum of 2099 (all youths); and all lipids and apolipoprotein B, 439 (adolescents aged 12-19 years) in 2007-2008 and 532 (adolescents aged 12-19 years) in 2013-2014.
All lipids includes triglycerides and HDL, LDL, non-HDL, and total cholesterol.